Trial Profile
Double-blind randomized placebo effects Imeglimin on insulin secretion during a hyperglycemic clamp diabetic subjects with type 2
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Sep 2015
Price :
$35
*
At a glance
- Drugs Imeglimin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Poxel
- 11 Sep 2014 New trial record